Maria Rodrigues
Clinical Researcher
Papers
Trials
Key Impact
Notable for contributing a series of real-world studies on repeated intravenous ketamine infusions for treatment‑resistant mood disorders and for work examining contextual factors in psychedelic therapy such as the role of music.
Background & Research
Published under the name N. B. Rodrigues, the researcher has contributed to a body of clinical and real‑world research focused on rapid-acting antidepressant treatments, particularly intravenous ketamine, and on contextual elements of psychedelic-assisted therapies. Their work includes multi-topic observational analyses from the Canadian Rapid Treatment Center of Excellence examining frequency of symptomatic worsening after ketamine infusions, and real‑world effectiveness studies of repeated ketamine infusions across diverse clinical populations — transitional‑age youth, patients with comorbid borderline personality disorder, and individuals with treatment‑resistant bipolar depression. Rodrigues has also contributed to scholarship on non‑pharmacological determinants of outcome in psychedelic therapy, for example the central role of music as a therapeutic adjunct.
The publications indicate an emphasis on translational, clinic-based evidence: safety and tolerability signals (including suicidal ideation outcomes), effectiveness in routine care settings, and the practical implications of providing repeated ketamine treatment to complex patient groups. Full given names for N. B. Rodrigues were not available in the supplied records; the profile therefore summarises contributions and thematic expertise as reflected in the listed studies.